rdf:type |
|
lifeskim:mentions |
umls-concept:C0013089,
umls-concept:C0017262,
umls-concept:C0017817,
umls-concept:C0024121,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0242643,
umls-concept:C0334094,
umls-concept:C0439849,
umls-concept:C0441655,
umls-concept:C0683598,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
1992-9-8
|
pubmed:abstractText |
This study analyzed whether proliferative activity and expression of P-glycoprotein 170 (P-170) or glutathione S-transferase-pi (GST-pi) in human non-small cell lung carcinomas (NSCLC) represent independent factors in resistance to doxorubicin or whether an association exists between these factors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
764-9
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:1353700-Adult,
pubmed-meshheading:1353700-Aged,
pubmed-meshheading:1353700-Biopsy,
pubmed-meshheading:1353700-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:1353700-Cell Division,
pubmed-meshheading:1353700-Doxorubicin,
pubmed-meshheading:1353700-Drug Resistance,
pubmed-meshheading:1353700-Female,
pubmed-meshheading:1353700-Glutathione Transferase,
pubmed-meshheading:1353700-Humans,
pubmed-meshheading:1353700-Immunohistochemistry,
pubmed-meshheading:1353700-Isoenzymes,
pubmed-meshheading:1353700-Lung Neoplasms,
pubmed-meshheading:1353700-Male,
pubmed-meshheading:1353700-Membrane Glycoproteins,
pubmed-meshheading:1353700-Middle Aged,
pubmed-meshheading:1353700-P-Glycoprotein,
pubmed-meshheading:1353700-Thymidine
|
pubmed:year |
1992
|
pubmed:articleTitle |
Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors.
|
pubmed:affiliation |
Department of Experimental Pathology, German Cancer Research Center, Heidelberg.
|
pubmed:publicationType |
Journal Article
|